In summary, PFN-1 may serve as a novel regulator that mediates the effects of AGEs-activated RhoA/ROCK signaling pathway on the redistribution of actin cytoskeleton, and inhibition of PFN-1 expression can protect against cardiomyocytes injury and cardiac dysfunction in diabetes. Here, RHOA is linked to diabetes mellitus.